Pfizer has just bought Trillium Therapeutics (TRIL.NAS)… for U$2.2bn (AUD$3.1bn)… PFE are paying $18.50/shr. Trillium was trading at 28c in November 2019…
Importantly, TRIL targets CD47.. they are currently in P1b/2 across several indications
”DEVELOPING NOVEL IMMUNOTHERAPIES FOR CANCER WITH A FOCUS ON CD47 BLOCKADE”
https://trilliumtherapeutics.com
Pfizer takeover of CD47 blocking Co.
Add PER (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
7.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $68.51M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 173062 | 7.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 7.9¢ | 26980 | 2 |
View Market Depth
| Last trade - 10.20am 21/05/2024 (20 minute delay) ? |
| PER (ASX) Chart |
Day chart unavailable